Results 151 to 160 of about 18,928 (205)

Impact of Body Mass Index on Clinical Outcomes in Myocardial Infarction Patients Undergoing Coronary Stenting with Dual Antiplatelet Therapy. [PDF]

Biomedicines
Lukács RA, Tornyos D, Jánosi A, Komócsi A.   +3 more
europepmc   +1 more source

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx). [PDF]

Br J Clin Pharmacol
Dello Russo C, Frater I, Kuruvilla R, Lip S, O'Neill H, Burke K, Chaplin V, Doney ASF, Elyas S, Greaves N, Harding S, Hargroves D, Hayward J, Hughes DA, Hughes TAT, Kondapally S, Mok P, Peace A, Rafi I, Ray S, Stinton V, Venetucci L, Pirmohamed M.   +22 more
europepmc   +1 more source

Sex-Related Differences in On-Treatment Platelet Reactivity in Patients with Acute Coronary Syndrome. [PDF]

Biomedicines
Mutschlechner D, Tsarouchas A, Tscharre M, Wadowski PP, Lee S, Pultar J, Weikert C, Panzer S, Gremmel T.   +8 more
europepmc   +1 more source

Entering a new era of antiplatelet therapy: the 4D-ACS trial. [PDF]

Eur Heart J Cardiovasc Pharmacother
Laudani C, Gragnano F, Galli M.
europepmc   +1 more source

A Case of Methemoglobinemia Suspected to Be Induced by Rabeprazole. [PDF]

Acute Med Surg
Kawasaki R, Toida C, Kamijo H, Akita M, Hattori M, Ichikawa M, Takayama H, Miyama H, Nitta K, Imamura H.   +9 more
europepmc   +1 more source

Intensive antithrombotic therapy is necessary for long-term treatment in patients with symptomatic peripheral artery disease after acute myocardial infarction. [PDF]

Sci Rep
Matejka J, Motovska Z, Hlinomaz O, Kala P, Hromadka M, Varvarovsky I, Dusek J, Jarkovsky J, Rokyta R, Mrozek J, Cervinka P, Simek S, Ostransky J.   +12 more
europepmc   +1 more source

Clinical Effectiveness and Safety of Reduced-Dose Prasugrel in Asian Patients: The PROMISE-TW Registry. [PDF]

J Clin Med
Wang YC, Lu CR, Shiao YT, Chang KC, Su CH, Chiu YW, Huang CL, Liu WS, Yu CL, Hsieh MJ, Lu YH, Su HM, Lin PC, Leu HB, Lee WL.   +14 more
europepmc   +1 more source

Interaction of CYP2C19 with the effect of clopidogrel in secondary prevention of major ischemic events: Systematic review and meta-analysis. [PDF]

Int J Stroke
Kremers FC, van den Biggelaar J, Lingsma HF, van Schaik RH, Roozenbeek B, Dippel DW.   +5 more
europepmc   +1 more source

Differences in P2Y₁₂ Reaction Units Between Prasugrel and Clopidogrel by Ischemic Cerebrovascular Disease Subtypes　- Subanalysis From ACUTE-PRAS. [PDF]

Circ Rep
Fujimoto S, Iguchi Y, Yamagami H, Koga M, Itabashi R, Yakushiji Y, Kowata K, Kimura N, Terasawa Y, Shimizu T, Miyazaki Y, Oki K, Masuo O, Matsuoka H, Arakawa S, Ueda T, Tanaka R, Hashimoto W, Abe S, Kato G, Furugori T, Kimura K, ACUTE-PRAS Investigators.   +22 more
europepmc   +1 more source